Showing results (1771-1780 of 1,902) with videos related to
Sort By:
Pageof 191
NPJ Vaccines|February 23, 2023
Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaquesCatherine Jacob-Dolan, Jingyou Yu, Katherine McMahan, et al.Cell|April 18, 2016
Rapid Inflammasome Activation following Mucosal SIV Infection of Rhesus MonkeysDan H Barouch, Khader Ghneim, William J Bosche, et al.Antimicrobial Agents and Chemotherapy|August 17, 2002
N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activityCorinne J Hackbarth, Dawn Z Chen, Jason G Lewis, et al.Nature Communications|March 6, 2021
Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus MacaquesAnthony M Cadena, John D Ventura, Peter Abbink, et al.Cell|September 21, 2023
Mpox infection protects against re-challenge in rhesus macaquesMalika Aid, Michaela Sciacca, Katherine McMahan, et al.Plos Biology|May 5, 2022
Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primatesDaniel Y Zhu, Matthew J Gorman, Dansu Yuan, et al.Biorxiv : the Preprint Server for Biology|April 5, 2022
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal modelsAlexander A Cohen, Neeltje van Doremalen, Allison J Greaney, et al.Science Translational Medicine|February 22, 2022
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaquesXuan He, Malika Aid, Abishek Chandrashekar, et al.Cell Host & Microbe|December 11, 2020
D614G Spike Mutation Increases SARS CoV-2 Susceptibility to NeutralizationDrew Weissman, Mohamad-Gabriel Alameh, Thushan de Silva, et al.Analytical Biochemistry|December 19, 2023
An assessment of a biosensor system for the quantification of microcystins in freshwater cyanobacterial bloomsJustin D Chaffin, Katelyn B Barker, Sarah R Bickman, et al.Pageof 191